Dilated Cardiomyopathy is conventionally defined by left ventricular dilatation and
dysfunction in the absence of coronary disease. Emerging evidence suggests many patients …

Dilated cardiomyopathy (DCM) defines a family of overlapping myocardial diseases caused
by innate susceptibility and/or acquired insults that occur in a diverse population of patients …

Abstract Aims Cardiomyopathies (CMPs) are a heterogeneous group of diseases that are
defined by structural and functional abnormalities of the cardiac muscle. Dilated …

Background Dilated cardiomyopathy (DCM) is a final common manifestation of
heterogenous etiologies. Adverse outcomes highlight the need for disease stratification …

Dilated cardiomyopathy (DCM) represents a particular aetiology of systolic heart failure that
frequently has a genetic background and usually affects young patients with few co …

Dilated cardiomyopathy (DCM) represents one of the most common causes of non-ischemic
heart failure, characterised by ventricular dilation alongside systolic dysfunction. Despite …

Dilated Cardiomyopathy (DCM) has a straightforward and apparently “simple” definition: a
heart muscle disease characterized by left ventricular (LV) or biventricular dilation and …

Dilated cardiomyopathy (DCM) is a major cause of heart failure and cardiovascular mortality.
In the past 20 years, there has been an overwhelming focus on developing therapeutics that …

Recent advances in cardiac MRI (CMR) capabilities have truly transformed its potential for
deep phenotyping of the diseased heart. Long known for its unparalleled soft tissue contrast …

Dilated cardiomyopathy (DCM) is a leading cause of heart failure and life-threatening
ventricular arrhythmias (LTVA). Work-up and risk stratification of DCM is clinically …